Sponsored Research
Carey Anders of Oncology has received an award from the 5 for the Fight for a project entitled "Dr. Anders-Cancer Research." Total funding will be $6,693.
Andrew Armstrong of Oncology has received an award from the Department of Defense for a project entitled "DoD: PCRP Clinical Consortium: Duke University Clinical Research Site." Total funding will be $1,932,000.
Carl Berg of Gastroenterology has received a sub-award through the Northwestern University for a project entitled "Utility of Biomarkers of Rejection and Kidney Injury in Tailoring Liver Transplant Immunosuppression." Total funding will be $59,631.
Maria Blasi of Infectious Diseases has received an award from the National Institutes of Health for a project entitled "Developmental Core, a part of Priyamvada Acharya's project entitled "Duke Center for HIV Structural Biology"." Total funding will be $0.
Megan Clowse of Rheumatology has received an award from the Department of Defense for a project entitled "Improving Quality of Life in SLE by Stratified Personalized Health Planning." Total funding will be $2,499,921.
Kimberley M. El (Mentor: Jonathan Campbell) of Endocrinology has received an award from the Juvenile Diabetes Research Foundation for a project entitled "Targeting alpha-cell GPCRs to stimulate glucagon and counter hypoglycemia." Total funding will be $65,683.
Jennifer Freedman of Oncology has received an award from the Susan G. Komen Breast Cancer Foundation for a project entitled "Ancestry-related RNA splicing and immune expression in metastatic breast cancer." Total funding will be $499,997.
Thomas Leblanc of Cell Therapy has received an award from the Leukemia & Lymphoma Society for a project entitled "Patient Experience Research and Palliative Care Integration in Malignant Hematology." Total funding will be $124,977.
Robert McGarrah III of Cardiology has received an award from the National Institutes of Health for a project entitled “Mechanisms Connecting Dysregulated Branched-Chain Alpha-Ketoacid Metabolism to Cardiac Dysfunction.” Total funding will be $2,620,290.
Mehri McKellar of Infectious Diseases has received a sub-award (X07HA00051) through the NC Dept of Health and Human Services for a project entitled "NCDHHS RFA # A-379 -Region 7 Ryan White Part B Network of Care-Continuous Funding." Total funding will be $432,034.
Mehri McKellar of Infectious Diseases has received a sub-award (NB01-OT009312-) through the NC DHHS for a project entitled "Choosing Life: Empowerment Action! Results! (CLEAR) and Integrated Targeted Testing Services (ITTS)." Total funding will be $129,000.
Ranee Chatterjee Montgomery of General Internal Medicine has received a sub-award (1R01-HL155396-01A1) through the Duke Clinical Research Institute for a project entitled "Coronary Artery Calcium in PRagmatic EValuation of evENTs And Benefits of Lipid-lowering in oldEr adults (CAC PREVENTABLE Ancillary Study)." Total funding will be $1.
Nwora Okeke of Infectious Diseases has received an award from the National Institutes of Health for a project entitled “Leveraging Local Health System Electronic Health Record Data to Enhance PrEP Access in Southeastern Louisiana: A Community-Informed Approach (R01).” Total funding will be $4,141,885.
Joshua Thaden of Infectious Diseases has received an award from the National Institutes of Health for a project entitled “Characterization of a Novel E. coli Type III Secretion System Associated with Increased Patient Mortality.” Total funding will be $894,728.
Nathan Thielman of Infectious Diseases has received a sub-award (5D43-TW0009337-11) through the Vanderbilt University Medical Center for a project entitled "Bridging the Service Gap for Pediatric Mental Health Care in the Western Cape Province of South Africa." Total funding will be $99,157.
Rahima Zennadi of Hematology has received an award (1R01-HL160697-01) from the National Institutes of Health for a project entitled "Oxidative stress mechanisms regulating gamma-globin gene transcription in sickle cell disease." Total funding will be $2,360,214.
Industry-Sponsored Clinical Trials
Cristiana Costa Chase of Cell Therapy has received an award from Genentech, Inc. for a project entitled "LARC multicenter retrospective Center-Based Chart Review." Total funding will be $14,049.
Melissa Daubert of Cardiology has received an award from VisCardia, Inc. for a project entitled "Viscardia - RCT_Echo Lab - Industry." Total funding will be $60,948.
Darin Dufault of Gastroenterology has received an award from Ethicon Endo-Surgery, Inc. for a project entitled "TRX-2021-05 North Carolina Blue Cross Blue Shield Esophageal Therapeutics (NC BEST) Registry." Total funding will be $264,186.
Terry Fortin of Cardiology has received an award from Acceleron Pharma for a project entitled "A011-12 SOTERIA (An Open-Label Long-term Follow-up Study to Evaluate the Effects of Sotatercept When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH)." Total funding will be $830,847.
Ahmed Galal of Cell Therapy has received an award from CRISPR Therapeutics for a project entitled "A Phase 1, Open-Label, Multicenter, Dose Escalation and Cohort Expansion Study of the Safety and Efficacy of Anti-CD70 Allogeneic CRISPR-Cas9-Engineered T Cells (CTX130) in Adult Subjects with Relapsed or Refractory T or B Cell Malignancies." Total funding will be $1,798,999.
Ravi Karra of Cardiology has received an award from Alnylam Pharmaceuticals for a project entitled "A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Zilebesiran Used as Add-on Therapy in Patients with Hypertension Not Adequately Controlled by a Standard of Care Antihypertensive Medication." Total funding will be $448,879.
Igor Klem of Cardiology has received an award from Bayer HealthCare, LLC for a project entitled "CMR evaluation of ED patients presenting with chest pain, abnormal troponin values and low HEART-Score." Total funding will be $195,600.
William Herzog of Cardiology has received an award from Merck Sharp & Dohme for a project entitled "VICTOR - Vericiguat Outcomes Study in HFrEF." Total funding will be $481,371.
Matthew McKinney of Cell Therapy has received an award from Genentech, Inc. for a project entitled "Phase III Randomized, Open-Label, Multicenter Study Evaluating Efficacy and Safety of Mosunetuzumab in Combination with Lenalidomide in Comparison to Rituximab in Combination with Lenalidomide in Patients with Follicular Lymphoma After at Least One.” Total funding will be $513,151.
Lake Morrison of Pulmonary has received an award from Fibrogen, Inc. for a project entitled "FGCL-3019-095 Pro00108483 Zephyrus II: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects with Idiopathic Pulmonary Fibrosis (IPF)." Total funding will be $307,464.
April Salama of Oncology has received an award from Ascentage Pharma Group for a project entitled "A Phase Ib/II Study of APG-115 in Combination with Pembrolizumab in Patients with Unresectable or Metastatic Melanomas or Advanced Solid Tumors." Total funding will be $162,414.
Myles Wolf of Nephrology has received an award from Boehringer Ingelheim Pharmaceuticals, Inc. for a project entitled "Protecting Kidney and Cardiovascular Health long after Kidney Transplant." Total funding will be $0.